Chih Kai Cheng
Director/Board Member bei PRIMAX ELECTRONICS LTD.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Cheng Liu | M | 57 |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 18 Jahre |
| Ying Yi Xiao | M | 66 | 8 Jahre | |
| Li Sheng Liang | M | 79 | 15 Jahre | |
| Shu Chuan Chang | M | - | 7 Jahre | |
| Chau Wai-Yan | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Ying Chuan Shen | M | - | 3 Jahre | |
| Chia Chi Wang | M | - | 5 Jahre | |
| Chia Pin Tu | M | 66 | 3 Jahre | |
| Yong Zhong Pan | M | 67 | 17 Jahre | |
| Yong Tai Pan | M | 71 | 17 Jahre | |
| Chun Pang Wu | M | - | 6 Jahre | |
| Han Zhong Li | M | 56 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 5 Jahre |
| Vivien Chan | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 10 Jahre |
| William S. Solari | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| You Min Kuo | M | - | 6 Jahre | |
| Chi Jen Li | M | 67 | 3 Jahre | |
| Chen Wei Wang | M | - |
B Current Impact Investment, Inc.
| - |
| Jacqueline Northcut | F | 62 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Michael Cannon | M | 78 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Marvin Samson | M | 82 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Yung Kuang Chu | M | - |
Social Enterprise Insights
| - |
| Bo Feng | M | 53 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Brian Pan | M | - |
H3 Platform, Inc.
 H3 Platform, Inc. Information Technology ServicesTechnology Services H3 Platform, Inc. is a composable infrastructure solutions provider that was founded in 2014. It is based in New Tapei City, Taiwan. The Taiwanese company aims to be a leader in its field. The CEO is Brian Pan. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Yi Ping Li | M | - | 3 Jahre | |
| Tai Chao Ku | M | - | 12 Jahre | |
| Benjamin Xu | M | - |
Harbinger Venture Management
 Harbinger Venture Management Investment ManagersFinance Harbinger ventures Management (Harbinger ventures) is a venture capital firm founded in 2000 by chih kai cheng. The firm is headquartered in Cupertino ,California. | - |
| Mao Jung Lin | M | 69 |
Harbinger Venture Management
Harbinger Venture Management Investment ManagersFinance Harbinger ventures Management (Harbinger ventures) is a venture capital firm founded in 2000 by chih kai cheng. The firm is headquartered in Cupertino ,California. | - |
| Tina Chen | F | - |
Harbinger Venture Management
Harbinger Venture Management Investment ManagersFinance Harbinger ventures Management (Harbinger ventures) is a venture capital firm founded in 2000 by chih kai cheng. The firm is headquartered in Cupertino ,California. | - |
| Kuohsiung Li | M | - |
Harbinger Venture Management
Harbinger Venture Management Investment ManagersFinance Harbinger ventures Management (Harbinger ventures) is a venture capital firm founded in 2000 by chih kai cheng. The firm is headquartered in Cupertino ,California. | - |
| Tze-Ting Yang | M | 71 | 11 Jahre | |
| Chia Lun Liu | M | - | 4 Jahre | |
| Bing Qing Chen | M | 62 | 4 Jahre | |
| Chieh Chi Chen | M | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Taiwan | 24 | 72,73% |
| Vereinigte Staaten | 9 | 27,27% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Chih Kai Cheng
- Persönliches Netzwerk
